IL36B and colorectal carcinoma: Although there was a difference in colonic IL-36β production in the CRC compared to non-cancer control, there was no significant difference in overall survival period of the CRC patients between IL-36βhigh and IL-36βlow (P > 0.05, Fig. 2c).